The global heparin market size is expected to reach USD 11.43 billion by 2027, exhibiting a CAGR of 3.9% during the forecast period. The increasing cases of cardiovascular diseases such as deep vein thrombosis & pulmonary embolism are expected to spur demand for heparin in the forthcoming years, states Fortune Business Insights, in a report, titled “Heparin Market Size, Share & Industry Analysis, By Product Type (Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH)), By Source (Bovine, and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion, and Subcutaneous Injection), By End User (Hospitals & ASCs, Clinics, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 8.39 billion in 2019.
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/sample/heparin-market-104447
The report on theheparin market reveals:
- Prominent insights into the industry
- Noteworthy data about major companies
- Emerging trends and drivers
- Comprehensive analysis of the segments
- COVID-19 effect on the industry
Heparin Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
For more information visit : https://www.fortunebusinessinsights.com/heparin-market-104447
Rising Incidence ofChronic Disorders to Incite Business Development
The increasing prevalence of cardiovascular diseases around the world, including heart attacks and strokes will spur opportunities for the market. As per the American Heart Association (AHA) Heart Disease and Stroke Statistics, an estimated 5.3 million Americans suffered from atrial fibrillation in 2019. The growing demand for heparin among patients can have an excellent impact on the market. As per the Centers for Disease Control and Prevention, coronary heart disease is the most common type of heart disease, killing 365,914 people in 2017.4. About 18.2 million adults age 20 and older have CAD (about 6.7%). Moreover, 2 in 10 deaths from CAD happen in adults less than 65 years old. The increasing awareness about the benefits of heparin in the treatment and management of heart diseases will improve the prospects of the market in the foreseeable future.
Minimal Impact on the Market During COVID-19
The limitations on non-essential medical procedures and consultations has had a drastic impact on the global market amid COVID-19. The healthcare industry has observed a decline in other medical services besides coronavirus. The increased emphasis on COVID’s vaccine has reduced the demand for other therapeutics. Furthermore, the lack of supply and production of heparin will simultaneously limit the scope of the market. However, government initiatives, including heavy investments and free medical aid will influence the healthy growth of the market in the time of the pandemic.
Quick Buy – Heparin Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/104447
High Adoption of Advanced Products to Boost Market in North America
The market size in North America stood at USD 4.28 billion in 2019. The growth in the region is attributed to the prevalence of cardiovascular diseases such as pulmonary embolism. The higher adoption of advanced heparin products will have an excellent effect on the market in the region. The increasing healthcare expenditure is expected to foster the healthy growth of the market in North America. The presence of major companies can further enhance the development of the market in the region. Europe is expected to hold the largest share owing to the acceptance of technologically advanced products in the region. The rising number of patients suffering from a range of cardiovascular diseases will further spur opportunities in the region. Asia Pacific is expected to experience a rapid growth rate owing to the growing patient population. The surging healthcare expenditure in the developing nations will have a tremendous effect on the market in Asia Pacific.
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/heparin-market-104447
Key Development:
May 2019: Pfizer, Inc. announced that it has received the approval from the U.S. FDA for the administration of its heparin product offering, Fragmin to minimize the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and above.
The Report Lists the Key Companies in the Heparin Market:
- Opocrin S.p.A. (Formigine, Italy)
- Baxter (Deerfield, U.S.)
- Pfizer Inc. (New York, U.S.)
- Bioiberica S.A.U. (Barcelona, Spain)
- Fresenius SE & Co. KGaA (Bad Homburg, Germany)
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China)
- Braun Melsungen AG (Melsungen, Germany)
- Reddy’s Laboratories Ltd. (Hyderabad, India)
- LEO Pharma A/S (Ballerup, Denmark)
- Aspen Holdings (Durban, South Africa)
- Other Players
Global Heparin Market Segmentation :
By Product Type
- UFH
- LMWH
By Source
- Bovine
- Porcine
By Application
- Deep Vein Thrombosis & Pulmonary Embolism
- Atrial Fibrillation
- Heart Attacks
- Stroke
- Others
By Route of Administration
- Intravenous Infusion
- Subcutaneous Injection
By End-User
- Hospitals & ASCs
- Clinics
- Others
By Geography
- North America
- By Product Type
- By Source
- By Application
- By Route of Administration
- By EndUser
- By Country
Table Of Contents :
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments – Mergers, Acquisitions, and Partnerships
- New Product Launches
- Prevalence of Key Cardiovascular Diseases, By Key Countries
- China Heparin Market Overview
- Blood Clots: Stats & Facts
- Overview of Technological Advancements in Heparin
- Impact of COVID-19 on the Global Heparin Market
- Regulatory Scenario by Key Countries
- Reimbursement Scenario by Key Countries
- Trends of Heparin Consumption in Muslim-oriented Markets
- Insights on Usage of Unfractionated Heparin (UFH) & Low Molecular Weight Heparin (LMWH)
- China Heparin Market Overview (Production/ Supply Impacted by Swine Fever, etc.)
- Purchasing Process – Heparin
- Pricing of Heparin
- Global Heparin Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
- Market Analysis, Insights and Forecast – By Source
- Bovine
- Porcine
- Market Analysis, Insights and Forecast – By Application
- Deep Vein Thrombosis & Pulmonary Embolism
- Atrial Fibrillation
- Heart Attacks
- Stroke
- Others
- Market Analysis, Insights and Forecast – By Route of Administration
- Intravenous Infusion
- Subcutaneous Injection
- Market Analysis, Insights and Forecast – By End User
- Hospitals & ASCs
- Clinics
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
- North America Heparin Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Product
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
- Market Analysis – By Source
- Bovine
- Porcine
- Market Analysis – By Application
- Deep Vein Thrombosis & Pulmonary Embolism
- Atrial Fibrillation
- Heart Attacks
- Stroke
- Others
- Market Analysis, Insights and Forecast – By Route of Administration
- Intravenous Infusion
- Subcutaneous Injection
- Market Analysis – By End User
- Hospitals & ASCs
- Clinics
- Others
- Market Analysis – By Country
- U.S.
- Canada
- U.S. Heparin Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Product
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
- Market Analysis – By Source
- Bovine
- Porcine
- Market Analysis – By Application
- Deep Vein Thrombosis & Pulmonary Embolism
- Atrial Fibrillation
- Heart Attacks
- Stroke
- Others
- Market Analysis, Insights and Forecast – By Route of Administration
- Intravenous Infusion
- Subcutaneous Injection
- Market Analysis – By End User
- Hospitals & ASCs
- Clinics
- Others
Get your Customized Research Report:https://www.fortunebusinessinsights.com/enquiry/customization/heparin-market-104447
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Press Release:https://www.fortunebusinessinsights.com/press-release/global-heparin-market-10316